1. Home
  2. ASPN vs CLLS Comparison

ASPN vs CLLS Comparison

Compare ASPN & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$5.19

Market Cap

407.5M

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$1.43

Market Cap

394.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
CLLS
Founded
2001
1999
Country
United States
France
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
394.4M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
ASPN
CLLS
Price
$5.19
$1.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$4.25
★ $8.33
AVG Volume (30 Days)
★ 808.6K
171.5K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $271,103,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$50.03
$0.98
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.30
$1.25
52 Week High
$9.35
$5.48

Technical Indicators

Market Signals
Indicator
ASPN
CLLS
Relative Strength Index (RSI) 49.56 24.03
Support Level $4.84 $1.25
Resistance Level $5.48 $3.47
Average True Range (ATR) 0.26 0.16
MACD 0.04 -0.06
Stochastic Oscillator 44.39 7.96

Price Performance

Historical Comparison
ASPN
CLLS

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: